Collegium Pharmaceutical
COLL
$36.42
Share price
1.62%
Change (1 day)
59.46%
Change (1 year)
Categories
Collegium Pharmaceutical (COLL) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $0.94 B
According to Collegium Pharmaceutical 's latest financial reports the company's total liabilities are $0.94 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Collegium Pharmaceutical - Total liabilities on balance sheet (from 2014 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | $0.94 B | -3.21% |
| 2022-12-31 | $0.97 B | 100.2% |
| 2021-12-31 | $0.48 B | 6.85% |
| 2020-12-31 | $0.45 B | 109.17% |
| 2019-12-31 | $0.21 B | 9.62% |
| 2018-12-31 | $0.19 B | 534.08% |
| 2017-12-31 | $31.48 M | 16.15% |
| 2016-12-31 | $27.1 M | 114.37% |
| 2015-12-31 | $12.64 M | -27.03% |
| 2014-12-31 | $17.33 M | 402.06% |
| 2013-12-31 | $3.45 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 United Therapeutics UTHR | $1.18 B | 24.72% | 🇺🇸 USA |
 Agile Therapeutics
AGRX | $23.3 M | -97.54% | 🇺🇸 USA |
 Horizon Therapeutics
HZNP | $3.98 B | 320.71% | 🇮🇪 Ireland |
 KemPharm KMPH | $29.72 M | -96.86% | 🇺🇸 USA |